A cost-utility analysis of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction
Year of publication: |
2020
|
---|---|
Authors: | Hansen, Svenn Alexander ; Aas, Eline ; Solli, Oddvar |
Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 21.2020, 1, p. 73-84
|
Subject: | Erectile dysfunction | Diabetes | Cost-effectiveness analysis | Cost-utility analysis | Phosphodiesterase type 5 inhibitors | CEAC | EVPI | Kosten-Nutzen-Analyse | Cost-benefit analysis | Kosten-Wirksamkeits-Analyse | Gesundheitsökonomik | Health economics |
-
Pöhlmann, J., (2020)
-
Jordan, Karen, (2023)
-
Applying the three core concepts of economic evaluation in health to education in the UK
Hinde, Sebastian, (2019)
- More ...
-
Pecuniary compensation increases participation in screening for colorectal cancer
Aas, Eline, (2009)
-
Rocco, Lorenzo, (2016)
-
Joranger, Paal, (2020)
- More ...